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ABSTRACT
Objective Blindness from retinopathy of prematurity 
(ROP) in middle- income countries is generally due to 
absence of screening or inadequate screening. The 
objective of this study was to assess uptake of services in 
an ROP programme in four district- level special newborn 
care units in India.
Design Cross- sectional study.
Setting All four neonatal units of a state in India where 
model programme for ROP had been introduced
Patients Infants eligible for screening and treatment of 
ROP between March and May 2017.
Intervention Data on sex, birth weight and gestational 
age of eligible infants were collected and medical records 
reviewed for follow- up.
Main outcome measures Proportion of eligible infants 
screened and for those screened, age at first screening, 
completion of screening, diagnosis and treatment received 
if indicated. The characteristics of infants screened and not 
screened were compared.
Results 137 (18%) of the 751 infants eligible for 
screening were screened at least once, with no statistically 
significant difference by sex. The mean birth weight and 
gestational age of those screened were significantly lower 
than those not screened. Among those screened, 43% 
underwent first screening later than recommended and 
44% had incomplete follow- up. Fourteen infants (11% 
of those screened) were diagnosed with ROP. Five were 
advised laser treatment and all complied.
Conclusion Uptake, completion and timing of first 
screening was suboptimal. Some planned interventions 
including training of nursing staff, use of integrated data- 
management software and providing material for parent 
counselling, which have been initiated, need to be fully 
implemented to improve uptake of ROP screening services.
BACKGROUND
India, like many other middle- income coun-
tries, is facing an epidemic of retinopathy of 
prematurity (ROP), which is emerging as an 
important cause of childhood blindness.1 It 
has been estimated that approximately 10% 
of 32 200 infants who become blind or visually 
impaired worldwide every year live in India.2 
There are several reasons for the increase in 
ROP blindness in India, including the recent 
increase in the number of neonatal intensive 
care units (NICUs), which is increasing the 
survival of preterm infants. In some of these 
units, neonatal care may be of suboptimal 
quality, which can expose preterm infants to 
modifiable risk factors such as unregulated 
supplemental oxygen, sepsis and failure to 
gain weight.3 4 In many middle- income coun-
tries, ROP screening and treatment has not 
expanded commensurately, and the same 
applies to India where majority of ROP blind 
infants received care in NICUs without ROP 
services.5 6 For example, a study in eight states 
in India showed that only 30% of NICUs had 
regular ROP screening.7
Components of an ideal ROP programme 
include adherence to national guidelines 
and protocols, committed trained teams of 
health workers and engagement of parents.8 
What is known about the subject?
 ► Screening and urgent treatment of retinopathy of 
prematurity (ROP) is effective at preventing most 
blindness due to ROP.
 ► Most ROP blindness in preterm infants is due to 
lack of screening, inadequate screening or delayed 
screening.
 ► Few studies report the proportion of preterm infants 
eligible for ROP screening who complete screening 
in a timely manner.
What this study adds?
 ► Despite systems to identify infants eligible for 
screening, only 18% got screened; among those, 
42.6% had delayed first screening and only 56.5% 
completed screening.
 ► More preterm, sicker infants were more likely to be 
screened than more mature, healthier infants.
 ► More robust systems are needed to ensure that all 
infants who require ROP screening are screened, 
particularly after discharge from the neonatal unit.
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In India, the Ministry of Health and Family Welfare’s 
Rashtriya Bal Swasthya Karakram programme for child 
health has drawn up screening criteria, which take 
account of the fact that in India larger and more mature 
babies develop ROP requiring treatment,9 10 up to 20% of 
whom would not have been screened if American criteria 
were followed.11 The current recommendations are that 
preterm infants or infants without known gestational age 
(GA) and with a birth weight (BW) up to 2000 g should 
be screened.12 Natural history of ROP requires the first 
screening to be at an appropriate interval after birth, 
according to national guidelines; in India, the recom-
mendation is by chronological age of 30 days regardless 
of GA.12 This decision was made for three main reasons; 
first, except for a very small numbers the majority of these 
preterm infants develop ROP by 4–5 weeks,13 second, it 
is easy for service providers and parents to understand 
and remember, and third, postmenstrual age cannot 
be used as GA is often unreliable. For a programme to 
be effective, it is important that all eligible infants are 
screened at the right time, which includes those who 
have been discharged or referred to a different unit,13 as 
failure to screen, or inadequate screening are important 
reasons why infants become blind from ROP despite a 
programme being in place.6 14
A recent programme, launched by the Ministry of 
Health in 2013, sought to address this, by building 
capacity in the government health system for ROP 
screening and treatment, focusing on infants admitted to 
special newborn care units (SNCUs) which now number 
more than 800 across the country.7 The programme, 
which ended in June 2019, was supported by the UK’s 
Queen Elizabeth Diamond Jubilee Trust (the Trust) and 
was managed by Indian Institute of Public Health Hyder-
abad. In this programme, infants admitted to 20 SNCUs 
in 4 states who met the eligibility criteria recommended 
in the national ROP guidelines12 were screened in the 
SNCU, and discharged infants were asked to return to 
the same hospital for further screening, if indicated. In 
this study, four SNCUs in one of the four states were 
visited 4 months after initiation of the programme and 
data of the first 3 months were included. In three SNCUs, 
screening was performed by an ophthalmologist working 
in another hospital in the district who visited on a desig-
nated day and time of the week. In the other SNCU, the 
ophthalmologist worked in the same hospital and was 
called to screen when required. Details of all infants 
admitted in SNCUs are recorded in a separate register 
which is completed by the senior nurse in- charge on 
duty. A high proportion (more than 90%) of SNCUs in 
the state also have a dedicated database with a data entry 
person. The data entered in the register and database 
includes date of admission, date of birth, BW, GA, diag-
noses and date of discharge. However, no data on ROP 
screening or treatment are entered into the admissions 
register nor the database.
The overall purpose of this study was to undertake an 
early evaluation of the Trust supported ROP programme 
in one of the four states. The objectives were to assess the 
uptake of ROP screening and treatment among eligible 
infants where this was indicated, and to compare the 
characteristics of infants who were or were not screened. 
Results on the availability of equipment, and practices 
and attitudes regarding oxygen monitoring have already 
been published.15
MATERIALS AND METHODS
The state selected for the study reflects the demographic 
profile of India16 with an infant mortality rate within ‘at- 
risk’ level for an impending ROP epidemic.17 All four 
SNCUs, which were randomly coded A, B, C and D to 
maintain confidentiality, were visited by the primary 
investigator (SS). In each SNCU, permission was sought 
before collecting data. A designated ROP nurse in each 
SNCU with responsibilities for managing the programme 
including documenting the findings of screening in a 
separate register (‘ROP register’) and patient general 
nursing records, assisted in data collection.
Data for this cross- sectional study were collected for 
the months of March, April and May 2017. To identify 
the number of infants eligible for screening, data were 
extracted from the SNCU database (one unit) or from 
the admissions register (three units). Data for BW and 
GA were collected for all babies eligible for screening and 
comparisons were made between those screened and not 
screened. For all eligible babies, data on screening were 
extracted from records maintained by the ROP nurse for 
inpatient and outpatient screening (all units). Data on 
outpatient screening was also being maintained at SNCU 
A by the screening ophthalmologists. The following data 
were extracted, whether the infant had been screened 
at all, and if so, then at the first and each subsequent 
screening episode: the date of screening and the medical 
management decision, including the need for treatment, 
and whether this was adhered to.
Definitions
Eligibility for screening was defined according to the 
Indian national guidelines, that is, BW ≤2000 g or GA 
<34 weeks, or GA between 34 and 36 weeks if exposed to 
factors such as prolonged supplemental oxygen, respira-
tory distress syndrome or blood transfusions.12 An infant 
was designated as ‘screened’ if they were screened even 
once. Screening was considered complete if the last 
follow- up visit had been attended or if an infant had 
missed only one follow- up visit. Follow- up was considered 
incomplete if more than one screening follow- up visit 
had been missed. Compliance with treatment was also 
recorded.
Patient and public involvement
It was not appropriate or possible to involve patients or 
the public in the design, conduct, reporting or dissemina-
tion plans of our research. Uptake was derived from the 
previous 3 months records. Results would be disseminated 
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to the public indirectly through the learnings incorpo-
rated in the information and education material
Data analysis
Data were analysed using R software, V.3.6. Analysis 
included calculation of means and SD and proportions 
with CIs. Tests for comparisons included the t- test for 
unpaired data, χ2 tests and analysis of variance.
Authors adhered to the Strengthening the Reporting 
of Observational Studies in Epidemiology cross- sectional 
reporting guidelines.18
RESULTS
Seven hundred and fifty- one infants were eligible for 
screening, these included 33 infants more than 37 weeks 
GA but BW <2000 g. 53% of eligible infants were male. 
Their mean BW was 1792.6 (SD 473.5, range 500–3750) g 
and their mean GA was 33.5 (SD 2.7 range 24–39) weeks. 
A total of 137 (18%) of the 751 infants were screened at 
least once, with no statistically significant difference by 
sex or SNCU (table 1).
Data for BW were missing for 1 screened and 6 non- 
screened infants and the same for GA was missing for 2 
screened and 13 non- screened infants. The mean BW 
of those screened was 1608.0 g (SD, 392.0) and those 
not screened was 1833.6 g (SD, 484.4); mean GA of 
those screened was 32.9 weeks (SD, 3.1) and those not 
screened was 33.6 weeks (SD, 2.6). Both BW and GA were 
significantly lower for those screened (p<0.001 for BW 
and p<0.05 for GA). 243 eligible neonates had a very low 
BW (<1500 g). A significantly higher proportion of these 
infants (25%) were screened than those with a BW of 
more than 1500 g (15%, p=<0.001).
Information on age at first screening was missing for 8 
of the 137 infants screened at least once. The mean age 
at first screening overall was 30.3 (range 1–60) days, with 
no differences by sex or SNCU (table 2). Forty- three per 
cent of infants underwent first screening after the recom-
mended chronological age of 30 days.
Among the 137 neonates screened, the follow- up data 
were missing for five infants and one infant who did not 
survive was excluded (table 3). Among the 131 infants 
with follow- up data, 57 (43%) had incomplete follow- up. 
A higher proportion of female than male infants had 
incomplete follow- up but the difference was not statisti-
cally significant (p=0.19), and the differences in rates of 
incomplete follow- up between SNCUs was also not statis-
tically significant.
Nine of the 137 infants were advised repeat screening 
because the retinal vessels were reported as being imma-
ture at the first examination with immature retinal vessels. 
Only one of these infants had complete the follow- up 
(rest were part of 57 incomplete follow- up). The overall 
screening and outcomes are depicted in figure 1.
Fourteen infants (11% of those screened) were diag-
nosed with ROP (figure 1, table 4), one of whom did not 
survive. Five developed signs of type 1 ROP,19 three in 
SNCU A and two in SNCU B. All were advised peripheral 
retinal laser ablation and all received treatment . Among 
the eight surviving infants with less severe ROP, six had 
complete follow- up and did not require treatment and 
two had incomplete follow- up (table 4).
The mean GA of the treated infants was 29.2 (range 
28–32 weeks) and the mean BW was 1231 (range 
930–1800) g (table 4). None fell outside the Indian BW 
screening criteria.
DISCUSSION
Our study was designed as an assessment of the Trust’s 
ROP programme, after early interventions in four SNCUs 
in rural districts of one of the states in India.While some 
of the interventions planned in the programme, such as 
having a trained ROP nurse had been fully implemented, 
other interventions, including training of other nursing 
staff, use of dedicated software for data management and 
providing materials for parent counselling and education 
in the local language, had been initiated but were not 
fully implemented at the time of this study.
In our study, there was poor uptake of any screening 
among eligible infants, as more than 80% were not 
screened at all. Similar findings have been reported in 
other studies in India, in which less than 40% of eligible 
babies were screened.20 21 In comparison, most studies 
from high- income countries report screening compli-
ance to be at least 80%, with most reporting rates in the 
range of 90%–95%.22–24
More than 40% of infants who were screened once 
and who required further screening did not complete 
the recommended number of visits. This attrition is 
much higher than in a study in rural southern India, 
which also identified failure to complete all screening as 
a major challenge, with failure to return for screening 
after infants were discharged from the unit being the 
main reason.19 Similar findings were reported in two 
Table 1 Proportion of eligible infants screened by sex and 
SNCU
Sex and SNCU Total eligible
Infants screened at 
least once, n (%)
Sex*
  Male 399 77 (19)
  Female 351 60 (17)
SNCU
  SNCU A 150 23 (15)
  SNCU B 198 36 (18)
  SNCU C 249 58 (23)
  SNCU D 154 20 (13)
Total 751 137 (18)
*One infant was of indeterminate sex.
SNCU, special newborn care unit.
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studies, from Brazil and Argentina,25 26 where incomplete 
follow- up accounted for around half of screening failures.
A limitation of our study is that data were not collected 
on whether the infants had been discharged from the 
neonatal unit, or whether they had died or were trans-
ferred to another unit before the first screening was due. 
In addition, parents of infants not screened were not 
contacted as the ROP nurses reported that the contact 
details in the medical records were often either absent or 
incorrect. These factors mean that we can only speculate 
why screening rates were so low.
In our study, dedicated ROP nurses had been trained, 
as shown effective previously,27 with designated work 
of identification of infants eligible for screening, 
making preparations for screening including dilating 
the infants, maintaining records and counselling the 
parents. However, systems were not in place to identify 
and document infants eligible for screening. Lists were 
not being created systematically, the need for screening 
was not documented in the admissions register, and 
contact details were unreliable. A first step to improve 
the proportion of eligible infants who are screened, is 
to draw the attention of neonatologists and ophthalmol-
ogists involved in providing ROP screening to the fact 
that low access to screening can be a problem. Systems 
need to be put in place to ensure that all preterm babies 
eligible for screening are identified on admission to the 
neonatal unit, with clearly defined roles and responsibil-
ities. This should include documenting and compiling 
lists of babies to be screened, and communicating this 
to parents and screening ophthalmologists. Ideally 
electronic systems should be used, but if these are not 
available, a diary- based system can be used, where the 
name and contact details are entered on the date for the 
first or subsequent screening. A separate paper register 
can be used to track attendance, or this can be done 
using readily available software such as Excel. Training 
neonatologists, neonatal nurses and ophthalmologists 
should include these important aspects of service delivery. 
Community health workers,28 who focus on maternal and 
child health, could also be involved in ensuring screening 
after discharge.
In our study, the mean GA and BW of eligible infants 
were high, a high proportion of these infants were likely 
to have been discharged before 30 days. This is even 
more likely in overcrowded units, as if often the case in 
low- resource settings, where less preterm or sick infants 
are often discharged early. An effective way to increase 
the proportion of eligible infants who are screened, 
is to screen before discharge, even if this is a bit early. 
This identifies babies with mature retinal vessels who do 
not need further screening, and importantly, increases 
awareness among parents who comply better with 
follow- up thereafter, as previously demonstrated in 
India.21 Indeed, in our study, over half of the infants who 
were screened once went on to complete all subsequent 
screening.
In our study first screening was beyond 30 days in 40% 
of infants. A delay in the first screening has also been high-
lighted as a problem in some high- income countries.22 29 
The implication of late screening is that the disease may 
progress beyond type 1 ROP before screening, particu-
larly in the presence of aggressive posterior ROP, which 
is a frequent occurrence in India.30
Table 2 Mean age of infants (in days) at first screening in each of four special newborn care units (SNCU)
SNCU
Male Female Total
No screened Mean days No screened Mean days Nor screened Mean days
SNCU A 6 26.3 15 25.1 21 25.4
SNCU B 22 31.1 14 32.1 36 31.5
SNCU C 35 30.0 21 32.2 56 30.8
SNCU D 11 35.7 5 25.0 16 32.4
Total 74 30.9 55 29.6 129 30.3
Table 3 Proportion of screened infants with completed follow- up
SNCU
Screened infants with 











follow- up, n(%) N (%)
SNCU A 19 5 4 (80) 14 8 (57) 12 (63)
SNCU B 35 21 16 (76) 14 9 (64) 25 (71)
SNCU C 57 35 17 (49) 22 10 (45) 27 (47)
SNCU D 20 13 9 (69) 7 1 (14) 10 (50)
Total 131 74 46 (62) 57 28 (49) 74 (57)
SNCU, special newborn care unit.
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In our study, the GA and BW were significantly higher 
among infants not screened than those who were, which 
differs from two other studies, one in Argentina and 
the other in the UK, in which smaller, more premature 
babies were less likely to have been screened.22 27 Our 
finding has several possible explanations, one being 
that more preterm, sicker infants had a longer inpatient 
stay and were still inpatients at 30 days. Other explana-
tions are that neonatal staff and/or parents may not 
have been convinced of the need for screening more 
mature, healthier babies. Although the staff was inter-
viewed regarding oxygen practices,15 the attitudes of 
staff regarding screening and of parents not reporting 
for screening, was not captured in this study. Sicker 
and more preterm infants may have been transferred 
to another more advanced unit before the data of first 
screening as these SNCUs are level II NICUs.31 Transfer 
to another neonatal unit is an important reason for 
failure to screening in high income countries.32 However, 
data for transfer were not recorded in the SNCU or with 
the ROP nurse.
Any ROP was detected in approximately 10% of 
the infants screened in this study. This is less than the 
20%–40% reported in other Indian studies. However, 
most of these studies were conducted either in a tertiary 
level centre33 or level III NICUs34 35 unlike the SNCUs in 
the present study, which are level II. As only very few of 
the eligible infants were screened in the study SNCUs, 
this incidence may not be truly representative of SNCU 
population. In our study, all preterm infants requiring 
treatment received treatment.
Although establishing ROP screening in district level 
SNCUs is an important first step, challenges such as 
inadequate uptake of screening, delayed first screening 
and incomplete follow- up were detected in our study 
SNCUs. We recommend that fields for ROP along with 
accurate contact details be included in the neonatal data-
base which is used in many units in India, as this would 
provide a mechanism for identifying eligible babies and 
monitoring the uptake of screening among those who 
survive to 30 days. Robust systems and interventions 
are also required to ensure that all surviving eligible 
infants access screening in a timely manner. A further 
study, including interview of parents of infants who do 
not report for screening, is required in a large number 
of SNCUs to explore reasons for screening failures, that 
could lead to targeted interventions to increase uptake.
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